Sequent Scientific Limited
Sequent Scientific Limited stands as one of the largest global manufacturers of Veterinary Active Pharmaceutical Ingredients (APIs), distinguishing itself as a leading pure-play animal health company. The company holds the distinction of operating India’s sole USFDA-approved veterinary API facility and ranks among the top 20 animal health companies worldwide. Sequent’s expansive operations, which include seven manufacturing facilities, are equipped to produce a broad spectrum of APIs and Finished Dosage Formulations (FDFs) tailored for veterinary care across over 90 countries. Their business model centers on advancing animal healthcare through innovation, offering a comprehensive suite of products that includes APIs, FDFs, and analytical services designed to meet global industry demands. Sequent Scientific, through its dedication to R&D and manufacturing excellence, provides essential infrastructure and reliable ingredient supply, making it a pivotal partner in the development and manufacturing of next-generation veterinary medicines.
Latest Market Research Report on Veterinary API Download PDF Brochure Now
SUANFARMA
SUANFARMA is a leading global provider committed to preserving animal health and well-being through its specialized Veterinary API division. The company is recognized for offering an extensive portfolio of proprietary veterinary APIs designed to meet diverse customer needs across various therapeutic indications. These critical ingredients include compounds for reproductive health, potent antiparasitic agents like Fluralaner, and essential antibiotics such as Minocycline and Oxytetracycline. SUANFARMA emphasizes adherence to stringent regulatory standards, providing comprehensive documentation like Certificates of Suitability (CEP) and US Drug Master Files (US DMFs). Furthermore, the company supports the complete product life cycle by providing stable Finished Dosage Formulation (FDF) manufacturing technology that is fully compatible with their active ingredients. With EU GMP certified facilities and robust technical support, SUANFARMA plays a crucial role in the veterinary supply chain, providing high-quality, regulated raw materials necessary for effective animal therapeutics.
Zoetis
Zoetis is recognized as the world’s leading animal health company, with a strategic presence in the veterinary API market driven by its massive portfolio of finished veterinary pharmaceuticals, vaccines, diagnostics, and genetics. Spun off from Pfizer, Zoetis nurtures animal health by advancing care for pets and livestock globally. As a market leader, Zoetis’s operations necessitate a complex and secure supply chain for the Active Pharmaceutical Ingredients (APIs) required for its blockbuster products, including treatments for pain, dermatology, and parasiticides like Simparica TRIO and Apoquel. While they market final dosage forms, the scale of their manufacturing—recently expanded with new facilities for vaccine development and monoclonal antibodies—reinforces their critical influence over the veterinary API ecosystem. Zoetis drives innovation and dictates quality standards, significantly impacting both the development and supply of specialized APIs used in cutting-edge veterinary therapeutic solutions worldwide.
Merck Animal Health (MSD Animal Health)
MSD Animal Health, a division of Merck & Co., is a global pharmaceutical powerhouse deeply embedded in the veterinary sector, supplying a wide range of pharmaceutical and vaccine products for companion and livestock animals. As a top-tier animal health company, Merck’s extensive product line requires substantial and reliable sourcing of high-quality Active Pharmaceutical Ingredients (APIs). The company prioritizes efficacy, safety, and dependability, ensuring the APIs used in products such as Caninsulin and Nobivac are rigorously controlled. Their operations often involve close collaboration with specialized API manufacturers to maintain quality control across its expansive portfolio. Recent strategic acquisitions, such as the Elanco aqua business segment, further necessitate the integration of new API requirements for cold-water and warm-water aqua products, solidifying MSD Animal Health’s powerful position in shaping quality and compliance standards across the entire veterinary API supply chain.
Ofichem Group
The Ofichem Group, based in Europe, is a key specialized manufacturer focusing intensely on the development, production, and reliable supply of high-quality Active Pharmaceutical Ingredients (APIs) exclusively for the veterinary pharmaceutical industry. By specializing in this niche, Ofichem serves as a crucial partner for animal health companies globally, providing the essential chemical building blocks for safe and effective veterinary medicines. Their core expertise lies in complex chemical synthesis and ensuring strict regulatory compliance, enabling them to produce a wide array of active ingredients required for various therapeutic applications in companion and livestock animals. The company’s dedication to quality and specialization allows it to support the manufacturing needs of pharmaceutical clients who require a consistent supply of compliant veterinary APIs, validating its position as an important dedicated supplier within the global API value chain.
Latest Market Research Report on Veterinary API Download PDF Brochure Now